"Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against Sun Pharma Advanced Research Co Ltd regarding SPARC’s New Drug Application for PICS (Paclitaxel Injection Concentrate for Suspension)," the company said in a regulatory fling.
Abraxis Bioscience LLC dismisses patent infringement complaint against SPARC
More from Industry NewsMore posts in Industry News »
- Serum Institute could export 20-30 million vaccine doses a month to COVAX: Adar Poonawalla
- Pfizer booster shot 95.6 pc effective against Covid-19
- Novartis extends deal to make Pfizer/BioNTech vaccines
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya
- AstraZeneca launches Clinical Data and Insights division in India